Medical and psychosocial outcome of Scoliosis In-Patient Rehabilitation (SIR)
© Freidel et al; licensee BioMed Central Ltd. 2009
Published: 15 January 2009
In a doctoral thesis by the first author, the medical and psychosocial outcome of Scoliosis In-Patient Rehabilitation is examined. The results of this investigation are published in German only. Therefore, a presentation of his results in English will enhance the present literature in scoliosis treatment.
Materials and methods
One hundred and forty one female patients with idiopathic scoliosis took part in this prospective study (11–16 years of age n = 85 [Group I]; 17–21 years n = 23 [Group II]; and > 21 years n = 33 [Group III];). The following HRQL/anxiety questionnaires have been used: SF-36, BWF, CHQ, FKV and STAIK. Pain measurement was also performed (VRS). Clinical follow-up: ATR (Scoliometer), surface topography and vital capacity (VC). Additionally the patients have been asked about their satisfaction with respect to content and outcome of SIR. The evaluation included measurements before SIR (t1), directly after SIR (t2) and two months after SIR (t3).
Significant improvements have been found with respect to HRQL/anxiety and also with respect to pain (Group III; t3). Average lateral deviation, ATR and VC have also improved significantly after SIR. In addition, the patients were very satisfied with SIR contents and outcomes.
The results clearly demonstrate a positive influence of SIR on the patient suffering from scoliosis with respect to medical and psychosocial issues.
- Freidel K, Petermann F, Reichel D, Steiner A, Warschburger P, Weiss HR: Quality of life in women with idiopathic scoliosis. Spine. 2002, 27 (4): E87-91. 10.1097/00007632-200202150-00013.View ArticlePubMedGoogle Scholar
- Weiss HR, Steiner A, Reichel D, Petermann F, Warschburger P, Freidel K: Medizinischer Outcome nach stationärer Intensivrehabilitation bei Skoliose. Phys Med Rehab Kuror. 2001, 11: 100-103. 10.1055/s-2001-14437.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd.